Artificial intelligence is being used to find people with heart conditions before they even have symptoms ... When AF is identified and treated early it can be managed and the stroke risk reduced.
The warning comes as 499,068 people in England were diagnosed with dementia last month - an increase of 19,416 from 2023. By Fiona Callingham, Health Reporter specialising in medical studies ...
Torsemide ER is under clinical development by Sarfez Pharmaceuticals and currently in Phase II for Congestive Heart ... which treats edema associated with heart failure or kidney disease. The product ...
AZD-5462 is under clinical development by AstraZeneca and currently in Phase II for Congestive Heart Failure (Heart Failure). According to GlobalData, Phase II drugs for Congestive Heart Failure ...
THAT’S THE PART THAT YOU KNOW, CONGESTIVE HEART FAILURE. MEYER SAYS HE’S BEEN LOOKING TO JOIN A RESEARCH STUDY TO SEE IF HE CAN HELP FIND A BETTER TREATMENT FOR HEART FAILURE, SO I’M REALLY ...